Insider Transactions in Q2 2024 at Healthstream Inc (HSTM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Linda Rebrovick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+2.01%
|
-
|
|
Jun 06
2024
|
Terry Allison Rappuhn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+22.93%
|
-
|
|
Jun 06
2024
|
Jeffrey L Mclaren Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+5.5%
|
-
|
|
Jun 06
2024
|
Amir Alex Jahangir Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+50.0%
|
-
|
|
Jun 06
2024
|
Thompson Dent Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+0.84%
|
-
|
|
Jun 06
2024
|
Frank Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+0.54%
|
-
|
|
Jun 06
2024
|
Tate Deborah Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+4.53%
|
-
|
|
Jun 06
2024
|
William Stead Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+2.62%
|
-
|
|
May 30
2024
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
985
+0.48%
|
$26,595
$27.17 P/Share
|
|
May 01
2024
|
Scott Fenstermacher Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,000
-7.14%
|
$26,000
$26.19 P/Share
|